Paradiem LLC boosted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 9.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,670 shares of the biopharmaceutical company’s stock after buying an additional 320 shares during the quarter. Paradiem LLC’s holdings in […]
Hall Laurie J Trustee cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 12.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 110 shares of the biopharmaceutical company’s stock after selling 15 shares during the period. Hall Laurie J Trustee’s holdings in Regeneron Pharmaceuticals […]
Smithbridge Asset Management Inc. DE purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 4,276 shares of the biopharmaceutical company’s stock, valued at approximately $3,085,000. Several other institutional investors and […]
MetLife Investment Management LLC decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 1.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 28,501 shares of the biopharmaceutical company’s stock after selling 509 shares during the quarter. MetLife Investment Management LLC’s holdings in Regeneron Pharmaceuticals were worth $20,563,000 at the end […]
North Star Asset Management Inc. bought a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 280 shares of the biopharmaceutical company’s stock, valued at approximately $202,000. Other institutional investors […]